Home NewsAfrica Hepatitis Day: Undiagnosed hepatitis kills 124,000 Africans annually – WHO

Hepatitis Day: Undiagnosed hepatitis kills 124,000 Africans annually – WHO

by Haruna Gimba

By Haruna Gimba

The World Health Organisation (WHO) says more than 124,000 Africans die each year as a result of undiagnosed and untreated hepatitis.

WHO Regional Director for Africa, Dr Matshidiso Moeti disclosed this in her message to commemorate World Hepatitis Day, aimed at increasing awareness of the disease under the theme: ‘Hepatitis can’t wait.’

Moeti said that the disease inflames the liver and can lead to liver cancer and cirrhosis, calling on all countries to rapidly improve access to services to prevent, diagnose and treat the disease.

Hepatitis is a silent epidemic with more than 90 million people living with the disease in Africa, representing 26 per cent of the global total, she noted.

The WHO director added that around 4.5 million African children, under five years, were infected with chronic hepatitis B, reflecting an enormous 70 percent of the global burden in that age group.

Moeti said that the global target of less than 1 per cent incidence of hepatitis B in children under 5 years has been reached, but the African region was lagging behind at 2.5 per cent.

‌She said that most of such cases could be prevented by eliminating the Mother-To-Child Transmission (PMTCT) of the disease, during or shortly after birth and in early childhood.

“Key interventions against hepatitis B include vaccination at birth and in early childhood, screening pregnant women, and providing timely treatment,” Moeti said.

She said that countries are been encouraged to integrate the hepatitis B PMTCT in the ante-natal care package together with the HIV and Syphilis PMTCT programme, especially after it was found that only 14 countries in the region were implementing the hepatitis B birth-dose vaccine.

“Among people who are infected, nine out of 10 have never been tested, because of limited awareness and access to testing and treatment.

“Even among countries offering hepatitis B birth-dose vaccine, health systems are facing challenges in ensuring pregnant women and mothers are tested and that those who test positive are treated,” she said.

Related Articles

Leave a Comment